Medline closed at $40.35 on Nov 4, up 18.36%, 19.3% below its highest close since Dec 17. Volume of 25.5M shares was 2.88× its 20-day average (well above normal).
Split-adjusted performance: +13.5% over one month, -4.0% over six months.
In the quarter ended Jun 27, 2026, revenue was $7.68B, with a net margin of 0.8%.
Short interest was 40.8M shares at the Oct 15 settlement, down 22.5% from the prior report (13.2% of float, 5.4 days to cover).